Óscar Manuel Peiró Ibáñez

6023-130. PATRONES DE USO DE LOS ANTIAGREGANTES PARENTERALES EN LA VIDA REAL EN PACIENTES SOMETIDOS A INTERVENCIONISMO CORONARIO PERCUTÁNEO

Óscar Manuel Peiró Ibáñez, Francisco Fernández Salinas, Octavio Raúl Jiménez Melo, Ana Marcano Fernández et autres

6124-10. GROWTH DIFFERENTIATON FACTOR 15 ¿UN BIOMARCADOR PARA GUIAR EL TRATAMIENTO CON EMPAGLIFLOZINA TRAS UN INFARTO AGUDO DE MIOCARDIO?

Óscar Manuel Peiró Ibáñez, María Ferrero Guillem, Anna Carrasquer Cucarella, Isabel Serrano Rodríguez et autres

6. EFECTO DE LA ADMINISTRACIÓN PREVIA DE ASPIRINA Y LA PRESENCIA DE DIABETES SOBRE LA MORTALIDAD A LARGO PLAZO EN PACIENTES CON SÍNDROME CORONARIO AGUDO

Anna Vidal Romero, María del Mar Rocamora Horrach, Juan René Delgado Cornejo, Norma Estrada et autres

Cumulative prognostic effect of diabetes and myocardial injury in patients attended in the emergency room

Víctor del Moral Ronda, Ramón Giménez, Norma Estrada, Guillermo Pineda et autres

Abstract Background Diabetes and myocardial injury are clinical conditions associated with cardiovascular events and increased mortality during follow-up. It is not known to what extent both conditions enhance their prognostic effect in patients seen in the emergency room with cardiac troponin determination. …

es (code pays fourni par la source)

The absence of standard modifiable cardiovascular risk factors does not predict better outcomes in patients with acute coronary syndrome

M I Gonzalez Del Hoyo, Óscar Manuel Peiró Ibáñez, K Vaquez-Nunez, F Dominguez Benito et autres

Abstract Introduction The standard modifiable cardiovascular risk factors (SMuRFs), like diabetes mellitus, hyperlipidemia,hypertension and smoking, are central elements of the well-established European Society of Cardiology SCORE calculator. However, acute coronary syndromes (ACS) in SMuRF-less individuals are not uncommon. Purpose Our study aimed …

es (code pays fourni par la source)

P6437Growth differentiation factor-15 and stromal cell-derived factor-1 as long-term prognosis biomarkers in acute coronary syndrome

Óscar Manuel Peiró Ibáñez, Núria Farré, A. Sebio García, Gil Bonet et autres

Abstract Introduction After an acute coronary syn bdrome (ACS) patients are at high risk of cardiovascular morbidity and mortality. In this scenario, Growth differentiation factor-15 (GDF-15) and Stromal cell derived factor-1 (SDF-1) has been reported as potential biomarkers in ACS. However, there …

es (code pays fourni par la source)

P3825Long-term prognostic value of growth differentiation factor-15 in acute coronary syndrome

Óscar Manuel Peiró Ibáñez, A. Sebio García, Gil Bonet, Verónica Quintern et autres

Abstract Introduction Biomarkers plays a critical role in diagnostic, prognostication, and decision-making in cardiovascular medicine. Growth differentiation factor-15 (GDF-15) has been reported as a potential biomarker in acute coronary syndrome (ACS). However, there is limited data on the long-term prognostic value after …

es (code pays fourni par la source)